Cortical gets chance to shine in front of Korean investors
Published 18-AUG-2016 15:26 P.M.
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
BPH Energy (ASX:BPH) investee company Cortical will be granted an opportunity to present its brain scanning technology to potential South Korean investors as part of a trade delegation.
It told the market today that Cortical has been invited by the Australian Trade and Investment Commission to present at the Austrade Medtech Innovation Showcase to be held in Korea.
In attendance will be senior executives from some of Korea’s leading pharmaceutical and medical device companies – attending at a time when the Korean Ministry of Science, ICT, and Future Planning has identified brain research as one of the five main fields to receive funding.
The Korean government has also recently launched the “Creative Economy” industry policy, which is aims to revitalise the Korean manufacturing sector through investment in advanced manufacturing capability in the materials, biotechnology, and healthcare sector.
The partnership between the Australian and Korean biotechnology sectors is also expected to grow on the back of the Free Trade Agreement signed between the two nations at the end of 2014.
News of Cortical’s involvement in the trade delegation comes shortly after it was selected as a semi-finalist in the Australian Technologies Competition (ATC).
The awards are an opportunity for small to medium technology companies to showcase their wares to judges from companies such as Deloitte, Bird&Bird, and FB Rice.
The competition has generated $250 million in investment over the past five years, and over 120 companies have benefitted from the competitions ongoing mentoring program.
There is no indication as yet if BPH will be a beneficiary, so don’t base your investment decision on their selection alone and approach any investment decision with caution.
Selection in the semi-finals of the competition is somewhat of a boon for Cortical, as the competition this year is not only focusing on technology but the ability for a company to globally scale their business.
In both cases, Cortical will be showcasing its brain function monitor (BAR) technology, which purportedly improves on the currently used EEG technologies by incorporating the latest advances in understanding of how the brains rhythmic electrical activity is produced.
The BARs underlying algorithm produces EEG indexes which are directly related to the physiological state of the patient’s brain.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.